Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Knee Relieve Patch
Brand Name
Sumifun Knee Relieve Patch
Generic Name
Knee Relieve Patch
Active Ingredient
BorneolCategory
Non-Standardized Chemical Allergen [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1.2 g/1001 | PATCH | TOPICAL | 83781-007 |
Detailed information about Sumifun Knee Relieve Patch
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sumifun Knee Relieve Patch, you must consult a qualified healthcare professional.
Borneol is a bicyclic organic compound and terpene derivative classified as a non-standardized chemical allergen. It is utilized in diagnostic patch testing and as a pharmacological penetration enhancer in various topical and traditional formulations.
Because Borneol is primarily used as an adjuvant or a diagnostic tool rather than a primary therapeutic agent, there is no single 'standard' oral dose established by the FDA for disease treatment. However, clinical patterns of use provide the following guidelines:
Since Borneol metabolites are excreted renally, patients with Stage 3 or higher Chronic Kidney Disease (CKD) should use products containing Borneol with caution. While systemic accumulation from topical use is low, impaired clearance could theoretically increase the risk of CNS side effects.
Borneol is heavily metabolized by the liver. Patients with hepatic cirrhosis or acute liver failure may experience prolonged half-lives of the compound. Dose reduction or avoidance is advised in severe hepatic impairment to prevent potential hepatotoxicity or neurotoxicity.
Elderly patients often have thinner skin (increasing topical absorption) and reduced renal clearance. Healthcare providers should monitor for signs of confusion or dizziness, which may be exacerbated by Borneol’s CNS activity.
If you miss a topical application, apply it as soon as you remember. If it is nearly time for your next application, skip the missed dose and resume your regular schedule. Do not double the amount applied to 'catch up.'
Signs of Borneol overdose (particularly following oral ingestion or excessive topical use over large surface areas) include:
In the event of suspected overdose or accidental ingestion, contact a Poison Control Center (1-800-222-1222 in the US) or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or apply Borneol-containing products to larger areas of the body than recommended without medical guidance.
When used topically or in diagnostic settings, the most common side effects are localized to the site of application. These include:
Systemic absorption, though limited, can cause the following in sensitive individuals:
> Warning: Stop using Borneol and call your doctor immediately if you experience any of these serious symptoms:
No FDA black box warnings currently exist for Borneol. However, it is important to note that the FDA does not regulate many botanical products containing Borneol with the same rigor as prescription drugs. Users should be aware that the concentration of Borneol in 'natural' products can vary significantly, increasing the risk of unexpected side effects.
Report any unusual symptoms or persistent skin irritation to your healthcare provider. If you suspect you are having a serious reaction, discontinue use and seek emergency care immediately.
Borneol is a potent chemical compound that must be handled with caution. Its primary risk factors involve its potential as an allergen and its ability to enhance the absorption of other chemicals. Patients should be aware that Borneol is not 'just a natural fragrance' but a pharmacologically active terpene that can cross biological barriers.
For patients using Borneol as part of a chronic treatment regimen (e.g., in certain integrative medicine protocols), the following monitoring may be necessary:
Borneol may cause dizziness or mild sedation in some individuals, particularly if absorbed systemically. Use caution when driving or operating heavy machinery until you know how Borneol affects you. If you experience lightheadedness, avoid these activities immediately.
Alcohol may potentiate the CNS depressant effects of Borneol. Furthermore, alcohol can increase skin permeability, potentially increasing the systemic absorption of topically applied Borneol. It is advisable to limit alcohol consumption while using products containing this compound.
There is no known 'withdrawal syndrome' associated with the discontinuation of Borneol. However, if you are using it to manage pain, symptoms may return upon stopping. If a severe allergic reaction occurs, discontinuation must be immediate and permanent.
> Important: Discuss all your medical conditions, especially neurological and skin disorders, with your healthcare provider before starting any product containing Borneol.
While there are few absolute drug-drug contraindications for topical Borneol, the following should be avoided when systemic exposure is possible:
Borneol is a known penetration enhancer. This means its most serious interaction is increasing the potency and toxicity of other drugs:
For each major interaction, the mechanism is usually related to pharmacokinetic enhancement (increased absorption) or pharmacodynamic synergism (additive CNS effects). The management strategy typically involves avoiding application to large surface areas and monitoring for the side effects of co-administered medications.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you use topical patches or integrative botanical formulas.
Borneol must NEVER be used in the following circumstances:
In these cases, a healthcare provider must perform a careful risk-benefit analysis:
Patients should be aware of potential cross-reactions with:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of seizures or skin sensitivities, before prescribing or recommending Borneol.
In traditional clinical practice, Borneol is categorized as a substance that 'invigorates blood' and is often contraindicated during pregnancy. There is a theoretical risk that Borneol may stimulate uterine smooth muscle, potentially leading to miscarriage or preterm labor. Furthermore, because Borneol crosses the placenta and the blood-brain barrier, the developing fetal nervous system may be at risk. Its use during pregnancy is generally discouraged unless the benefits clearly outweigh the risks, and only under strict medical supervision.
It is unknown if Borneol is excreted in human breast milk. However, many terpenes are known to pass into milk and can alter its taste or potentially cause sedation/irritability in the nursing infant. Due to the lack of safety data and the sensitivity of infant nervous systems to terpenes, breastfeeding women should avoid applying Borneol-containing products to the chest area and should consult a doctor before systemic use.
Borneol is not FDA-approved for pediatric use. Children have a higher surface-area-to-body-mass ratio, which significantly increases the risk of systemic toxicity from topical applications. There are numerous reports of terpene-induced seizures in children. Healthcare providers typically recommend avoiding Borneol in children under 12 years of age, and it is absolutely contraindicated in infants.
Elderly patients are at an increased risk for adverse effects from Borneol due to:
In patients with a Glomerular Filtration Rate (GFR) below 30 mL/min, the clearance of conjugated Borneol metabolites is likely reduced. While short-term topical use is generally safe, chronic use should be avoided to prevent the accumulation of metabolites that could theoretically revert to active forms or cause systemic irritation.
Patients with Child-Pugh Class B or C hepatic impairment should avoid Borneol. The liver's reduced capacity for glucuronidation (the primary detoxification pathway for Borneol) increases the risk of neurotoxicity and may further stress compromised hepatic tissue.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment before using any terpene-based products.
Borneol's primary pharmacological significance lies in its role as a biochemical modulator. Its molecular mechanism involves:
Borneol exhibits a rapid onset of action when used as a penetration enhancer, with effects on skin permeability occurring within minutes. Its CNS effects are dose-dependent; low doses may be perceived as refreshing or clarifying (due to TRPM8 activation), while high doses are distinctly sedative. It does not typically show the development of pharmacological tolerance with intermittent use, though skin sensitization (an immune response) can occur.
| Parameter | Value |
|---|---|
| Bioavailability | High (Oral >80%, Topical variable) |
| Protein Binding | Low (estimated <40%) |
| Half-life | 1 - 4 hours |
| Tmax | 0.5 - 2 hours (Oral) |
| Metabolism | Hepatic (CYP2B6, Glucuronidation) |
| Excretion | Renal (>90% as metabolites) |
Borneol is classified as a Non-Standardized Chemical Allergen [EPC]. It is also categorized as a Terpene and a Pharmaceutical Adjuvant/Penetration Enhancer. It is related to other bicyclic monoterpenes such as Camphor and Thujone.
Common questions about Sumifun Knee Relieve Patch
Borneol is primarily used in two ways: as a diagnostic tool and as a medical adjuvant. In dermatology, it is used in patch tests to identify patients with allergic contact dermatitis who may be sensitive to certain fragrances or botanical products. In pharmacology, it is frequently used as a 'penetration enhancer' in topical creams and patches to help other medications, like pain relievers, absorb more deeply into the skin. It is also a common component in traditional Asian medicine formulations, where it is believed to improve the delivery of other herbs to the brain and heart. Additionally, it is used as a flavoring agent and fragrance in various consumer products.
The most common side effects of Borneol are localized skin reactions, especially when it is used in patches or topical ointments. Users often report redness, itching, and a mild burning or stinging sensation at the site of application. Because it is a terpene, it also produces a strong cooling sensation similar to menthol, which some people may find uncomfortable. If absorbed systemically in larger amounts, it can cause mild dizziness, headache, or nausea. In rare cases, individuals may develop a full allergic rash (hives) that spreads beyond the area where the product was applied.
It is generally recommended to avoid or strictly limit alcohol consumption while using products containing Borneol, especially if they are taken orally or applied to large areas of the skin. Alcohol can increase the permeability of your skin and the blood-brain barrier, which may lead to higher-than-normal levels of Borneol entering your system. Since both alcohol and Borneol can affect the central nervous system, combining them may increase the risk of side effects like dizziness, drowsiness, and impaired coordination. Always consult your healthcare provider about the safety of alcohol with your specific medications.
Borneol is generally not recommended for use during pregnancy. Historically, it has been classified in traditional medicine as a substance that can stimulate the uterus, which theoretically increases the risk of miscarriage or early labor. Modern scientific data on its safety in human pregnancy is very limited, but because it is known to cross the placenta and reach the developing fetus, most healthcare providers advise against its use. If you are pregnant or planning to become pregnant, you should avoid products containing Borneol unless specifically directed by your doctor. Always prioritize safer, well-studied alternatives during pregnancy.
The onset of action for Borneol depends on how it is being used. When applied topically as a penetration enhancer, it begins to affect the skin barrier almost immediately, typically within 5 to 15 minutes. If used for its cooling analgesic effects, the sensation usually peaks within 20 to 30 minutes. When taken orally in complex formulations, it is absorbed rapidly, reaching peak levels in the bloodstream within 30 minutes to 2 hours. However, because it is often an 'assistant' to other drugs, the time it takes to see a therapeutic benefit will also depend on the primary medication it is helping.
Yes, Borneol can generally be stopped suddenly without the risk of withdrawal symptoms. It does not cause physical dependence like opioids or benzodiazepines. However, if you are using a product containing Borneol to manage chronic pain or inflammation, stopping it may cause your symptoms to return. If you are using it as part of a prescribed treatment plan, you should consult your healthcare provider before discontinuing it to ensure that your condition remains properly managed. If you are stopping it because of an allergic reaction, you should stop immediately and notify your doctor.
If you miss a dose of a topical product containing Borneol, apply it as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and continue with your regular routine. Do not apply extra amounts of the product to make up for a missed dose, as this can increase the risk of skin irritation or systemic absorption. For oral supplements containing Borneol, the same rule applies: skip the missed dose if the next one is near. Consistency is helpful, but doubling up on terpene-based products is not recommended.
There is currently no clinical evidence to suggest that Borneol causes weight gain. It is not a hormonal medication, nor does it significantly affect metabolic rate or appetite in a way that would lead to changes in body weight. Most uses of Borneol are topical or short-term diagnostic, which further minimizes any risk of systemic metabolic changes. If you experience unexpected weight gain while using a product containing Borneol, it is likely due to another ingredient in the formulation or an underlying medical condition, and you should discuss this with your healthcare provider.
Borneol can interact with other medications, primarily by increasing their absorption. Because it is a 'penetration enhancer,' it can make other topical drugs (like steroid creams or anti-inflammatory gels) much stronger, which might lead to more side effects. More importantly, it can affect the Blood-Brain Barrier, potentially changing how much of a brain-active medication (like those for epilepsy or depression) reaches your central nervous system. You must tell your doctor about all the medications you are taking, including over-the-counter drugs and supplements, before using Borneol to avoid these 'enhancement' interactions.
Borneol itself is a natural chemical compound and is not a 'branded' prescription drug in the traditional sense, so the concept of 'generic vs. brand' doesn't apply in the same way as it does for drugs like Lipitor or Advil. It is available from many different suppliers as a bulk chemical, a component of various essential oils, or an ingredient in many different over-the-counter patches and traditional medicines. When buying products containing Borneol, it is important to look for high-quality, standardized products, as the concentration and purity of the compound can vary significantly between different manufacturers.
Other drugs with the same active ingredient (Borneol)